Staveris S, Jung L, Jamet G, Koffel J C
J Chromatogr. 1985 Feb 27;338(1):79-88. doi: 10.1016/0378-4347(85)80072-4.
A highly sensitive and selective quantitative assay for unchanged veralipride has been developed. The compound is extracted from alkalized samples (plasma or urine) with dichloromethane and converted to its trimethylated derivative by reaction with trimethylanilinium hydroxide. The reaction mixture is then chromatographed on a 3% OV-1 column. Trimethylated derivatives of plasma samples were assayed by selected-ion monitoring in the chemical-ionization mode and quantified by comparing the intensity of the quasi-molecular ion m/z 426 (M + H) with the intensity of the corresponding ion from trideuterated internal standard, m/z 429 (M + H). Flame-ionization detection was used for the assay of urine samples. The peak height ratio of trimethylated veralipride over trimethylated sulpiride, the internal standard, was used for quantitation of urine samples. A relative standard deviation of less than 10% was found when quantifying 10 ng/ml veralipride in plasma or 1 microgram/ml in urine.
已开发出一种用于测定未变化的维拉必利的高灵敏度和高选择性定量分析方法。该化合物从碱化的样品(血浆或尿液)中用二氯甲烷萃取,并通过与氢氧化三甲基苯胺反应转化为其三甲基化衍生物。然后将反应混合物在3% OV - 1柱上进行色谱分析。血浆样品的三甲基化衍生物通过化学电离模式下的选择离子监测进行测定,并通过将准分子离子m/z 426(M + H)的强度与来自氘代内标物的相应离子m/z 429(M + H)的强度进行比较来定量。火焰离子化检测用于尿液样品的分析。尿液样品的定量采用三甲基化维拉必利与内标物三甲基化舒必利的峰高比。当对血浆中10 ng/ml的维拉必利或尿液中1微克/毫升的维拉必利进行定量时,相对标准偏差小于10%。